RUTI vaccine: Phase I data

Data from a 6-month, double-blind, placebo-controlled, Spanish Phase I trial in 24 healthy volunteers showed that 5, 25, 100 and 200 µg dosages of subcutaneous RUTI vaccine were well tolerated, with n...